Search - tctmd.com

Displaying 1 - 20 of 31

Sort: Relevancy | Date

Presentation TCT India 2025

Embolic Protection in TAVR: Present Status and Future

Presenter: Samir Kapadia

July 27, 2025

Presentation TVT 2023

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Presenter: Tamim Nazif

June 07, 2023

Presentation Miami Valves 2022

Do We Understand Neuroprotection Better?

Presenter: Carlos Alfonso

February 03, 2022

Presentation Live Valves 2019

TAVI: Cerebral Protection for Everyone

Presenter: Susheel Kodali

December 10, 2019

Presentation TCT Abstracts Posters 2019

Incidence, predictors and outcomes of periprocedural stroke in patients undergoing TAVR: Report from National Inpatient sample

Presenter: Moinuddin Syed

October 28, 2019

Presentation SIF 2019

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Presenter: Steven J Yakubov

March 30, 2019

Presentation SCAI 2018

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Presenter: Steven J Yakubov

April 28, 2018

Presentation JIM 2018

Prime Time For..."Protected TAVI"

Presenter: Martin B. Leon

February 23, 2018

Presentation

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll,

October 06, 2017

Presentation CDM 2017

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Presenter: John D. Carroll

October 06, 2017

Presentation LAA 2017

Left Atrial Appendage Occlusion as Adjunctive Therapy

Presenter: Amar Krishnaswamy

July 21, 2017

Presentation

Timing, Risk Factors, Outcomes of Stroke, TIA after TAVR: PARTNER Trial

Presenter: Samir Kapadia

September 12, 2016

Presentation

Neurological Events Following TAVR and Their Predictors: CoreValve Trials

Presenter: Neal Kleiman

September 12, 2016

Presentation TVT 2016

Strokes After TAVR: Etiologies, Declining Frequency, and Current and Future Therapies

Presenter: Samir R. Kapadia

June 17, 2016

Presentation TVT 2016

TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient

Presenter: Nirat Beohar

June 17, 2016

Presentation SOLACI 2016

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

Presenter: Martin B. Leon

June 10, 2016

Presentation Aortovascular 2015

Transfemoral TAVR: Current indications and results

Presenter: Susheel K. Kodali

September 19, 2015

Presentation

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Presenter: Johan Bosmans

July 14, 2015

Presentation TVT 2014

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Presenter: Axel Linke

June 07, 2014

Presentation TVT 2014

Why Cerebral Protection after TAVR Will Become the Standard of Care

Presenter: Eberhard Grube

June 07, 2014

Advertisement

Embolic Protection in TAVR: Present Status and Future

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

Do We Understand Neuroprotection Better?

TAVI: Cerebral Protection for Everyone

Incidence, predictors and outcomes of periprocedural stroke in patients undergoing TAVR: Report from National Inpatient sample

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Unresolved Issues: Cerebral Embolic Protection Use Selectively!

Prime Time For..."Protected TAVI"

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valvular Procedure: Is There Any Role for Embolic Protection?

Left Atrial Appendage Occlusion as Adjunctive Therapy

Timing, Risk Factors, Outcomes of Stroke, TIA after TAVR: PARTNER Trial

Neurological Events Following TAVR and Their Predictors: CoreValve Trials

Strokes After TAVR: Etiologies, Declining Frequency, and Current and Future Therapies

TVT 1039: Transcatheter Aortic Valve Replacement With Evolut-R CoreValve to Simultaneously Treat Severe Calcific Aortic Stenosis and a Large Aortic Root Pseudo-aneurysm in a High-risk Patient

Future Directions in TAVR: From Moderate-Low Risk Patients to New Devices

Transfemoral TAVR: Current indications and results

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

A Critical Analysis of Present Data on Cerebral Protection after TAVR

Why Cerebral Protection after TAVR Will Become the Standard of Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content